case_images: PMC8129158_01
case_images: Timeline.
case_images: fmed-08-638794-g0001.jpg
case_images: PMC8129158_01_fmed-08-638794-g0001.jpg
case_images: F1
case_images: She reported a 4-year history of lacrimal and parotid gland enlargement that progressed gradually without treatment (Figure 1).
case_images: (A) On admission. (B) Two weeks after treatment.
case_images: fmed-08-638794-g0002.jpg
case_images: PMC8129158_01_fmed-08-638794-g0002.jpg
case_images: F2
case_images: Bilateral lacrimal and parotid glands expanded substantially (Figure 2A). The enlargement of salivary glands and adenopathy alleviated substantially (Figure 2B).
case_images: (A) IgG staining. (B) IgG4 staining.
case_images: fmed-08-638794-g0003.jpg
case_images: PMC8129158_01_fmed-08-638794-g0003.jpg
case_images: F3
case_images: No sign of Castleman disease or lymphoma was identified (Figure 3).
case_images: PET-CT showed high glucose intake in salivary glands, lymph nodes, liver, and spleen.
case_images: fmed-08-638794-g0004.jpg
case_images: PMC8129158_01_fmed-08-638794-g0004.jpg
case_images: F4
case_images: An 18F-labeled fluorodeoxyglucose positron emission tomography identified high glucose intake in diffusely enlarged salivary glands, lymph nodes, liver, and spleen (Figure 4).